PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 95 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,439,305 | -13.0% | 1,556,247 | 0.0% | 0.96% | -10.4% |
| Q1 2023 | $3,952,867 | +35.7% | 1,556,247 | -0.1% | 1.08% | +43.4% |
| Q4 2022 | $2,912,173 | -27.2% | 1,557,312 | 0.0% | 0.75% | -31.7% |
| Q3 2022 | $4,002,000 | +33.2% | 1,557,312 | 0.0% | 1.10% | +55.6% |
| Q2 2022 | $3,005,000 | -35.0% | 1,557,312 | 0.0% | 0.71% | -25.3% |
| Q1 2022 | $4,625,000 | -28.6% | 1,557,312 | +7.9% | 0.95% | -27.0% |
| Q4 2021 | $6,480,000 | -0.7% | 1,443,312 | +7.4% | 1.30% | -6.6% |
| Q3 2021 | $6,528,000 | -17.7% | 1,343,312 | +15.5% | 1.39% | -8.4% |
| Q2 2021 | $7,933,000 | -3.4% | 1,163,312 | 0.0% | 1.52% | -1.5% |
| Q1 2021 | $8,212,000 | +41.2% | 1,163,312 | +25.2% | 1.54% | +37.2% |
| Q4 2020 | $5,817,000 | +22.3% | 929,312 | +5.7% | 1.12% | +13.8% |
| Q3 2020 | $4,757,000 | +60.9% | 879,312 | +55.2% | 0.98% | +53.2% |
| Q2 2020 | $2,957,000 | +101.3% | 566,552 | +21.4% | 0.64% | +90.2% |
| Q1 2020 | $1,469,000 | +36.8% | 466,552 | +75.0% | 0.34% | +61.0% |
| Q4 2019 | $1,074,000 | -6.7% | 266,552 | 0.0% | 0.21% | -12.1% |
| Q3 2019 | $1,151,000 | +8.3% | 266,552 | 0.0% | 0.24% | +5.3% |
| Q2 2019 | $1,063,000 | – | 266,552 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |